Patient Research Partnerships

merakoi joins your research consortium as the patient-voice work-package partner. We do not "support" patient voice as a side activity. We own a defined work package with reviewer-credible methodology, deliverables, timelines, and budget.

EU Horizon Europe, IMI / IHI, EIT Health, and national funding bodies. We co-build proposals with prime applicants and contribute the patient-voice methodology, design, and execution.

Letters of support are static: they signal intent but do not structure delivery. A work-package partnership defines what gets done, when, by whom, against what budget. Reviewers weight the latter heavily because it shows operational seriousness.

As early as possible, ideally during work-package scoping, before the methods section is drafted. Late engagement (post-submission, pre-launch) works but limits how deeply patient voice can be integrated into the project design.

Across 174 diseases and 20+ therapy areas, with depth in oncology, immunology, neurology, rare disease, and mental health. Recruitment timelines depend on disease prevalence and inclusion criteria. Typically 4 to 8 weeks from contract signature.

No — we operate as work-package lead, contributor, or subcontractor, whichever fits the consortium structure. We most often lead the patient-engagement WP because that's where we own the methodology end-to-end, but we also contribute to wider work packages (clinical, dissemination, ethics) and sit under another partner as a subcontractor when that's the right fit. The role is decided during proposal scoping — what matters is that patient and end-user voice has clear ownership and budget, not which seat at the table we hold.